This topic contains a solution. Click here to go to the answer

Author Question: Which statement is true about affective disorders? a. Monozygotic twins are less likely to ... (Read 55 times)

AEWBW

  • Hero Member
  • *****
  • Posts: 579
Which statement is true about affective disorders?
 
  a. Monozygotic twins are less likely to develop affective disorders than dizygotic twins.
  b. Relatives are 3 times more likely to develop affective disorders.
  c. There appears to be a link between circadian rhythm and depression.
  d. Sleep and affective disorders are not associated.

Question 2

Treatment for bipolar disorder includes:
 
  a. ECT.
  b. lithium.
  c. sleep deprivation.
  d. MAOIs.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

zoeyesther

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

Answer: C

Answer to Question 2

Answer: B




AEWBW

  • Member
  • Posts: 579
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


meow1234

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

To maintain good kidney function, you should drink at least 3 quarts of water daily. Water dilutes urine and helps prevent concentrations of salts and minerals that can lead to kidney stone formation. Chronic dehydration is a major contributor to the development of kidney stones.

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library